University of Florida Health .

Gainesville, Florida 32611

13 studies enrolling now · 58 studies all time

What they study most

Achalasia, Acute Pancreatitis, Advanced Solid Tumors, Astrocytoma, Grade IV, Astrocytoma, IDH-Mutant, Grade 2, Astrocytoma, IDH-Mutant, Grade 3, Astrocytoma, IDH-Mutant, Grade 4, Autoimmune Pulmonary Alveolar Proteinosis, Breast Cancer, Burn Injury, CRC (Colorectal Cancer), Cardiomyopathy

Studies at this site

• Adoptive T Cell Therapy, DC Vaccines, and Hematopoietic Stem Cells Combined With Immune checkPOINT Blockade in Patients With Medulloblastoma — Recruiting now
• A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer — Recruiting now
• A Study to Evaluate the Safety and Efficacy of a Single Dose of RABI-767 in Participants With Acute Pancreatitis — Recruiting now
• Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT) — Recruiting now
• SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance) — Recruiting now
• AtraUmatic Laparoscopic HerNia Repair Clinical Investigation to Evaluate the Safety and Performance of The ECLIPSIUM System for Mesh Fixation IDE — Recruiting now
• TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer — Recruiting now
• IL-8 Receptor-modified CD70 CAR T Cell Therapy in CD70+ Adult Glioblastoma — Recruiting now
• IMPRoving Outcomes in Vascular DisEase - Aortic Dissection — Recruiting now
• RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus — Recruiting now
• S-531011 as Monotherapy and in Combination With an Immune Checkpoint Inhibitor in Advanced or Metastatic Solid Tumors — Recruiting now
• Regeneration of Acutely Injured Nerves With Temporary Electrical Stimulation — Recruiting now
• Robotic Versus Open Ventral Hernia Repair — Recruiting now
• Misago® RX Self-expanding Peripheral Stent for Common and/or External Iliac Artery — Completed
• A Trial to Find Out How Safe REGN7075 is and How Well it Works in Combination With Cemiplimab for Adult Participants With Advanced Cancers — Running, not enrolling
• A Phase 1/2, Study Evaluating the Safety, Tolerability, PK, and Efficacy of Sotorasib (AMG 510) in Subjects With Solid Tumors With a Specific KRAS Mutation (CodeBreaK 100) — Completed
• Troriluzole in Adult Participants With Spinocerebellar Ataxia — Running, not enrolling
• Pivotal Study of the NanoKnife System for the Ablation of Prostate Tissue — Completed
• The Acute Burn ResUscitation Multicenter Prospective Trial — Completed
• DAY101 vs. Standard of Care Chemotherapy in Pediatric Participants With Low-Grade Glioma Requiring First-Line Systemic Therapy (LOGGIC/FIREFLY-2) — Running, not enrolling
• Single-Patient Expanded Access Protocol - RNA-LP in a Patient With Recurrent Osteosarcoma — NO_LONGER_AVAILABLE
• Expanded Access to Cyclic Irrigation in Patients Undergoing Exchange Arthroplasty — TEMPORARILY_NOT_AVAILABLE
• Study of Adjuvant Cemiplimab Versus Placebo After Surgery and Radiation Therapy in Patients With High Risk Cutaneous Squamous Cell Carcinoma — Running, not enrolling
• Study of Bictegravir/Emtricitabine/Tenofovir Alafenamide Fixed Dose Combination in Adolescents and Children With Human Immunodeficiency Virus-1 — Running, not enrolling
• Pivotal Clinical Trial Evaluating the Safety and Efficacy of the Fully Implanted Acclaim Cochlear Implant — Running, not enrolling
• Study Testing The Safety and Efficacy of Adjuvant Temozolomide Plus TTFields (Optune®) Plus Pembrolizumab in Patients With Newly Diagnosed Glioblastoma (2-THE-TOP) — Running, not enrolling
• IVTCC 2.0: A Prospective Multicenter Ventricular Tachycardia Catheter Ablation Registry — Enrolling by invitation
• ACTIV-6: COVID-19 Study of Repurposed Medications - Arm G (Metformin) — Completed
• ACTIV-6: COVID-19 Study of Repurposed Medications — Completed
• Pragmatic Randomized Trial of Proton vs. Photon Therapy for Patients With Non-Metastatic Breast Cancer: A Radiotherapy Comparative Effectiveness (RADCOMP) Consortium Trial — Running, not enrolling
• Clinical Trial of Inhaled Molgramostim Nebulizer Solution in Autoimmune Pulmonary Alveolar Proteinosis (aPAP) — Running, not enrolling
• Adherence and Outcome of Upper Airway Stimulation (UAS) for OSA International Registry — Status unconfirmed
• Trial of NanoPac Intratumoral Injection in Lung Cancer — Completed
• Changes in NT-proBNP, Safety, and Tolerability in HFpEF Patients With a WHF Event (HFpEF Decompensation) Who Have Been Stabilized and Initiated at the Time of or Within 30 Days Post-decompensation (PARAGLIDE-HF) — Completed
• A Registry Study of NanoKnife IRE for Stage 3 Pancreatic Cancer — Running, not enrolling
• Safety Study to Evaluate Immune Response of Vaccines in Participants With Relapsing Forms of Multiple Sclerosis Who Receive Ozanimod Compared to Non-Pegylated Interferon (IFN)-β or No Disease Modifying Therapy — Completed
• ACTIV-6: COVID-19 Study of Repurposed Medications - Arm F (Montelukast) — Completed
• A Gene Transfer Study for Hemophilia A — Completed
• ACTIV-6: COVID-19 Study of Repurposed Medications - Arm E (Fluvoxamine 100) — Completed
• Peroral Endoscopic Myotomy (POEM) for the Treatment of Achalasia — Completed
• Assessment of Patterns of Patient Reported Outcomes in Adults With Congenital Heart Disease - International Study II — Completed
• IBP-9414 for the Prevention of Necrotizing Enterocolitis - The Connection Study — Running, not enrolling
• Improving Diagnostic Standards in Dysphagia — Completed
• A Trial of CP101 for the Prevention of Recurrent CDI (PRISM4) — Stopped early
• ACTIV-6: COVID-19 Study of Repurposed Medications - Arm D (Ivermectin 600) — Completed
• ACTIV-6: COVID-19 Study of Repurposed Medications - Arm B (Fluvoxamine) — Completed
• ACTIV-6: COVID-19 Study of Repurposed Medications - Arm C (Fluticasone) — Completed
• ACTIV-6: COVID-19 Study of Repurposed Medications - Arm A (Ivermectin 400) — Completed
• Observational Study to Evaluate, Under Real-world Practice Conditions, the Safety and Effectiveness of Regorafenib in Patients Diagnosed With Unresectable Hepatocellular Carcinoma (uHCC) — Completed
• The PCORnet Blood Pressure Home Monitoring Study — Completed